PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275,268 | -29.7% | 44,832 | -28.3% | 0.00% | -50.0% |
| Q2 2023 | $391,438 | +63.9% | 62,530 | +24.9% | 0.00% | +100.0% |
| Q1 2023 | $238,772 | -46.2% | 50,057 | -1.8% | 0.00% | -50.0% |
| Q4 2022 | $443,439 | +17.3% | 50,970 | +60.3% | 0.00% | 0.0% |
| Q3 2022 | $378,000 | -15.6% | 31,790 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $448,000 | +10.6% | 31,470 | +61.8% | 0.00% | 0.0% |
| Q1 2022 | $405,000 | +39.7% | 19,450 | +55.0% | 0.00% | +100.0% |
| Q4 2021 | $290,000 | -22.5% | 12,550 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $374,000 | – | 12,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |